Identification Of Novel Biomarkers In Ovarian Cancer: Systems Biology Approaches

Agarwal, S., Saini, S., Parashar, D., Verma, A., Sinha, A., Jagadish, N., Batra, A., Suri, S., Gupta, A., Ansari, A.S. (2013). The novel cancer-testis antigen A-ki- nase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. Oncoimmunology 2, e24270.

Altomare, D.A., Testa, J.R. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455-7464.

Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355. Anam, M.T., Ishika, A., Hossain, M.B. (2015). A meta-analysis of hypoxia inducible factor 1-alpha (HIF1A) gene polymorphisms: association with cancers. Biomarker research 3, 29.

Antony, P.M., Balling, R., Vlassis, N. (2012). From systems biology to systems biomedicine. Current opinion in biotechnology 23, 604-608.

Aragon-Ching, J.B. (2014). The evolution of prostate cancer therapy: targeting the androgen receptor. Frontiers in oncology 4, 295.

Arend, R.C., Londoño-Joshi, A.I., Samant, R.S., Li, Y., Conner, M., Hidalgo, B., Alvarez, R.D., Landen, C.N., Straughn, J.M., Buchsbaum, D.J. (2014). Inhi- bition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer. Gynecologic oncology 134, 112-120.

Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. (2000). Gene Ontology: tool for the unification of biology. Nature genetics 25, 25-29.

Assenov, Y., Ramírez, F., Schelhorn, S.-E., Lengauer, T., Albrecht, M. (2008). Computing topological parameters of biological networks. Bioinformatics 24, 282-284.

Atiomo, W., Daykin, C. (2012). Metabolomic biomarkers in women with pol- ycystic ovary syndrome: a pilot study. Molecular human reproduction 18, 546-553.

Aviel-Ronen, S., Soriano, D., Shmuel, E., Schonman, R., Rosenblatt, K., Zadok, O., Vituri, A., Seidman, D., Barshack, I., Cohen, Y. (2014). Surgically treated ovarian endometriosis association with BRCA1 and BRCA2 mutations. Pat- hology-Research and Practice 210, 250-255.

Awwad, H.M., Geisel, J., Obeid, R. (2012). The role of choline in prostate cancer. Clinical biochemistry 45, 1548-1553.

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morrea- le, H.F., Futterweit, W., Janssen, O.E., Legro, R.S., Norman, R.J., Taylor, A.E. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and sterility 91, 456-488.

Bader, G.D., Betel, D., Hogue, C.W. (2003). BIND: the biomolecular interaction network database. Nucleic acids research 31, 248-250.

Bain, M.A., Faull, R., Fornasini, G., Milne, R.W., Evans, A.M. (2006). Accumulati- on of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrology Dialysis Transplantation 21, 1300-1304.

Banerji, C.R., Miranda-Saavedra, D., Severini, S., Widschwendter, M., Enver, T., Zhou, J.X., Teschendorff, A.E. (2013). Cellular network entropy as the energy potential in Waddington’s differentiation landscape. arXiv preprint arXiv:13107083.

Barabasi, A.-L., Oltvai, Z.N. (2004). Network biology: understanding the cell’s functional organization. Nature reviews genetics 5, 101-113.

Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., Marshall, K.A., Phillippy, K.H., Sherman, P.M., Holko, M. (2013). NCBI GEO: archive for functional genomics data sets—update. Nucleic acids re- search 41, D991-D995.

Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. cell 116, 281-297.

Bauckman K, Campla C, Nanjundan M. (2012) Dysregulated TGFB signaling in ovarian cancer, Ovarian Cancer - Basic Science Perspective, Farghaly S. eds, ISBN: 978-953-307-812-0, InTech.

Bauckman, K., Campla, C., Nanjundan, M. Dysregulated TGFβ Signaling in Ova- rian Cancer.

Becker, K.G., Barnes, K.C., Bright, T.J., Wang, S.A. (2004). The genetic association database. Nature genetics 36, 431-432.

Beckerman, R., Prives, C. (2010). Transcriptional regulation by p53. Cold Spring Harbor perspectives in biology 2, a000935.

Bellelis, P., Podgaec, S., Brão, M.M. (2011). Environmental factors and endometri- osis. Revista da Associação Médica Brasileira (English Edition) 57, 448-452. Bento, C., Andersson, M.K., Åman, P. (2009). DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2. BMC cell biology 10, 89.

Bernatsky, S., Ramsey-Goldman, R., Labrecque, J., Joseph, L., Boivin, J.-F., Petri, M., Zoma, A., Manzi, S., Urowitz, M.B., Gladman, D. (2013). Cancer risk in systemic lupus: an updated international multi-centre cohort study. Journal of autoimmunity 42, 130-135.

Bignotti, E., Tassi, R.A., Calza, S., Ravaggi, A., Romani, C., Rossi, E., Falchetti, M., Odicino, F.E., Pecorelli, S., Santin, A.D. (2006). Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early di- agnosis and therapy. Gynecologic oncology 103, 405-416.

Bignotti, E., Tassi, R.A., Calza, S., Ravaggi, A., Rossi, E., Donzelli, C., Todeschini, P., Romani, C., Bandiera, E., Zanotti, L. (2013). Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent mar- ker of better prognosis. Journal of translational medicine 11, 162.

Blazejczyk, A., Switalska, M., Chlopicki, S., Marcinek, A., Gebicki, J., Nowak, M., Nasulewicz-Goldeman, A., Wietrzyk, J. (2016). 1-methylnicotinamide and its structural analog 1, 4-dimethylpyridine for the prevention of cancer me- tastasis. Journal of Experimental & Clinical Cancer Research 35, 110.

Bodnar, L., Stanczak, A., Cierniak, S., Smoter, M., Cichowicz, M., Kozlowski, W., Szczylik, C., Wieczorek, M., Lamparska-Przybysz, M. (2014). Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer. Journal of ovarian research 7, 16.

Bolstad, B.M., Irizarry, R.A., Åstrand, M., Speed, T.P. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193.

Books, A. (2012). Endometriosis-Basic Concepts and Current Research Trends. Bordbar, A., Feist, A.M., Usaite-Black, R., Woodcock, J., Palsson, B.O., Famili, I.

(2011). A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC systems biology 5, 180.

Borhani, N., Manoochehri, M., Gargari, S.S., Novin, M.G., Mansouri, A., Omra- ni, M.D. (2014). Decreased expression of proapoptotic genes caspase-8-and BCL2-associated agonist of cell death (BAD) in ovarian cancer. Clinical Ova- rian and Other Gynecologic Cancer 7, 18-23.

Bovolenta, L.A., Acencio, M.L., Lemke, N. (2012). HTRIdb: an open-access data- base for experimentally verified human transcriptional regulation interacti- ons. BMC genomics 13, 405.

Bowen, N.J., Walker, L.D., Matyunina, L.V., Logani, S., Totten, K.A., Benigno, B.B., McDonald, J.F. (2009). Gene expression profiling supports the hypo- thesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC medical genomics 2, 71.

Brachova, P., Thiel, K.W., Leslie, K.K. (2013). The consequence of oncomorphic TP53 mutations in ovarian cancer. International journal of molecular scien- ces 14, 19257-19275.

Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., Karoly, E., Qin, L.X., Ye, Q.H., Jia, H.L. (2013). Integrated metabolite and gene expression profi- les identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology 144, 1066-1075. e1061.

Burotto, M., Chiou, V.L., Lee, J.M., Kohn, E.C. (2014). The MAPK pathway across different malignancies: a new perspective. Cancer 120, 3446-3456.

Buys, S.S., Partridge, E., Black, A., Johnson, C.C., Lamerato, L., Isaacs, C., Re- ding, D.J., Greenlee, R.T., Yokochi, L.A., Kessel, B. (2011). Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. Jama 305, 2295-2303.

Buys, T.P., Chari, R., Lee, E.H., Zhang, M., MacAulay, C., Lam, S., Lam, W.L., Ling, V. (2007). Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells. Genes, Chromosomes and Cancer 46, 1069-1079.

Cai, S.-Y., Yang, T., Chen, Y., Wang, J.-W., Li, L., Xu, M.-J. (2015). Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome. Journal of ovarian research 8, 50.

Calimlioglu, B., Karagoz, K., Sevimoglu, T., Kilic, E., Gov, E., Arga, K.Y. (2015). Tissue-specific molecular biomarker signatures of type 2 diabetes: an integrative analysis of transcriptomics and protein–protein interaction data. Omi- cs: a journal of integrative biology 19, 563-573.

Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101, 2999-3004.

Cannioto, R.A., Moysich, K.B. (2015). Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription. Gynecologic oncology 137, 559-573.

Capaccione, K.M., Pine, S.R. (2013). The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis, bgt127.

Carbon, S., Ireland, A., Mungall, C.J., Shu, S., Marshall, B., Lewis, S., Group, W.P.W. (2009). AmiGO: online access to ontology and annotation data. Bio- informatics 25, 288-289.

Cathcart, M.C., Gray, S.G., Baird, A.M., Boyle, E., Gately, K., Kay, E., Cummins, R., Pidgeon, G.P.,O’byrne, K.J. (2011). Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer. Cancer 117, 5121-5132.

Chagoyen, M., Pazos, F. (2011). MBRole: enrichment analysis of metabolomic data. Bioinformatics 27, 730-731.

Chakrabarty, A., Tranguch, S., Daikoku, T., Jensen, K., Furneaux, H., Dey, S.K. (2007). MicroRNA regulation of cyclooxygenase-2 during embryo implan- tation. Proceedings of the National Academy of Sciences 104, 15144-15149. Chandran, U.R., Ma, C., Dhir, R., Bisceglia, M., Lyons-Weiler, M., Liang, W., Mi- chalopoulos, G., Becich, M., Monzon, F.A. (2007). Gene expression profiles

of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC cancer 7, 64.

Chang, J.-H., Au, H.-K., Lee, W.-C., Chi, C.-C., Ling, T.-Y., Wang, L.-M., Kao, S.- H., Huang, Y.-H., Tzeng, C.-R. (2013). Expression of the pluripotent transc- ription factor OCT4 promotes cell migration in endometriosis. Fertility and sterility 99, 1332-1339. e1335.

Chatr-Aryamontri, A., Breitkreutz, B.-J., Oughtred, R., Boucher, L., Heinic- ke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O’donnell, L. (2015). The BioGRID interaction database: 2015 update. Nucleic acids research 43, D470-D478.

Cheaib, B., Auguste, A., Leary, A. (2015). The PI3K/Akt/mTOR pathway in ova- rian cancer: therapeutic opportunities and challenges. Chinese journal of cancer 34, 4.

Chen, C.-Y., Chen, S.-T., Fuh, C.-S., Juan, H.-F., Huang, H.-C. (2011). Coregulati- on of transcription factors and microRNAs in human transcriptional regula- tory network. BMC bioinformatics 12, S41.

Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., Sun, Y. (2015). New horizons in tumor microenvironment biology: challenges and opportunities. BMC medicine 13, 45.

Chen, L., Wang, S., Zhou, Y., Wu, X., Entin, I., Epstein, J., Yaccoby, S., Xiong, W., Barlogie, B., Shaughnessy, J.D. (2010). Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma. Blood 115, 61-70.

Chen, R., Alvero, A., Silasi, D., Kelly, M., Fest, S., Visintin, I., Leiser, A., Schwartz, P., Rutherford, T., Mor, G. (2008). Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene 27, 4712-4723.

Chen, Y.-F., Chen, Y.-T., Chiu, W.-T., Shen, M.-R. (2013). Remodeling of calcium signaling in tumor progression. Journal of biomedical science 20, 23.

Cheng, J.-C., Klausen, C., Leung, P.C. (2013a). Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer letters 329, 197-206.

Cheng, J., Chang, H., Leung, P. (2013b). Egr-1 mediates epidermal growth fa- ctor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Oncogene 32, 1041-1049.

Chiarugi, A., Dölle, C., Felici, R., Ziegler, M. (2012). The NAD metabolome—a key determinant of cancer cell biology. Nature Reviews Cancer 12, 741-752. Chin, C.-H., Chen, S.-H., Wu, H.-H., Ho, C.-W., Ko, M.-T., Lin, C.-Y. (2014).

cytoHubba: identifying hub objects and sub-networks from complex intera- ctome. BMC systems biology 8, S11.

Chittenden, B., Fullerton, G., Maheshwari, A., Bhattacharya, S. (2009). Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reproductive biomedicine online 19, 398-405.

Choi, C., Choi, J., Park, Y., Lee, Y., Song, S., Sung, C., Song, T., Kim, M., Kim, T., Lee, J. (2012). Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival. British journal of cancer 107, 91-99.

Chou, C.-H., Chang, N.-W., Shrestha, S., Hsu, S.-D., Lin, Y.-L., Lee, W.-H., Yang, C.-D., Hong, H.-C., Wei, T.-Y., Tu, S.-J. (2016). miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic acids research 44, D239-D247.

Chou, J., Werb, Z. (2012). MicroRNAs play a big role in regulating ovarian can- cer–associated fibroblasts and the tumor microenvironment. Cancer disco- very 2, 1078-1080.

Christian, S.L., Zu, D., Licursi, M., Komatsu, Y., Pongnopparat, T., Codner, D.A., Hirasawa, K. (2012). Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells. PLoS One 7, e44267.

Clevers, H., Nusse, R. (2012). Wnt/β-catenin signaling and disease. Cell 149, 1192-1205.

Corney, D.C., Hwang, C.-I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A.K., Kamat, A.A., Sood, A.K., Ellenson, L.H., Hermeking, H. (2010). Frequ- ent downregulation of miR-34 family in human ovarian cancers. Clinical Cancer Research 16, 1119-1128.

Creighton, C.J., Hernandez-Herrera, A., Jacobsen, A., Levine, D.A., Mankoo, P., Schultz, N., Du, Y., Zhang, Y., Larsson, E., Sheridan, R. (2012). Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS One 7, e34546.

Croce, C.M. (2009). Causes and consequences of microRNA dysregulation in cancer. Nature reviews genetics 10, 704-714.

Croft, D., O’Kelly, G., Wu, G., Haw, R., Gillespie, M., Matthews, L., Caudy, M., Ga- rapati, P., Gopinath, G., Jassal, B. (2010). Reactome: a database of reactions, pathways and biological processes. Nucleic acids research, gkq1018.

Cui, J., Zhu, L., Xia, X., Wang, H.Y., Legras, X., Hong, J., Ji, J., Shen, P., Zheng, S., Chen, Z.J. (2010). NLRC5 negatively regulates the NF-κB and type I interfe- ron signaling pathways. Cell 141, 483-496.

Cybulski, M., Jeleniewicz, W., Nowakowski, A., Stenzel-Bembenek, A., Tarkows- ki, R., Kotarski, J., Stepulak, A. (2015). Cyclin I mRNA Expression Correlates with Kinase Insert Domain Receptor Expression in Human Epithelial Ovari- an Cancer. Anticancer research 35, 1115-1119.

Dandara, C., Endrenyi, L., Kolker, E., Hekim, N., Steuten, L.M., Güngör, K., Ak- lillu, E., Özdemir, V. (2016). Precision Medicine 2.0: The Rise of Glocal Inno- vation, Superconnectors, and Design Thinking (Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA).

Davidson, B., Holth, A., Hellesylt, E., Hadar, R., Katz, B., Tropé, C.G., Reich, R. (2016). HUR mRNA expression in ovarian high-grade serous carcinoma ef- fusions is associated with poor survival. Human pathology 48, 95-101.

de la Fuente, A. (2010). From ‘differential expression’to ‘differential networking’– identification of dysfunctional regulatory networks in diseases. Trends in genetics 26, 326-333.

Deng, J., Wang, L., Chen, H., Li, L., Ma, Y., Ni, J., Li, Y. (2013). The role of tu- mour-associated MUC1 in epithelial ovarian cancer metastasis and progres- sion. Cancer and Metastasis Reviews 32, 535-551.

Desai, V., Prasad, N.R., Manohar, S.M., Sachan, A., Narasimha, S.R.P.V.L., Bitla,

A.R.R. (2014). Oxidative stress in non-obese women with polycystic ovarian syndrome. Journal of clinical and diagnostic research: JCDR 8, CC01.

Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., Furth, E.E., Lee, W.M., Enders, G.H., Mendell, J.T. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature genetics 38, 1060-1065.

Dezső, Z., Oestreicher, J., Weaver, A., Santiago, S., Agoulnik, S., Chow, J., Oda, Y., Funahashi, Y. (2014). Gene expression profiling reveals epithelial mesench- ymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells. PLoS One 9, e106131.

Didžiapetrienė, J., Bublevič, J., Smailytė, G., Kazbarienė, B., Stukas, R. (2014). Significance of blood serum catalase activity and malondialdehyde level for survival prognosis of ovarian cancer patients. Medicina 50, 204-208.

Dittmer, J. (2003). The biology of the Ets1 proto-oncogene. Molecular cancer 2, 29.

Dobbin, Z.C., Landen, C.N. (2013). The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer. International journal of mole- cular sciences 14, 8213-8227.

Doig, T.N., Hume, D.A., Theocharidis, T., Goodlad, J.R., Gregory, C.D., Freeman, T.C. (2013). Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC geno- mics 14, 469.

Dong, Y., Li, J., Han, F., Chen, H., Zhao, X., Qin, Q., Shi, R., Liu, J. (2015). High IGF2 expression is associated with poor clinical outcome in human ovarian cancer. Oncology reports 34, 936-942.

Duarte, N.C., Becker, S.A., Jamshidi, N., Thiele, I., Mo, M.L., Vo, T.D., Srivas, R., Palsson, B.Ø. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proceedings of the National Academy of Sciences 104, 1777-1782.

Ducros, E., Mirshahi, S., Azzazene, D., Camilleri-Broët, S., Mery, E., Al Farsi, H., Althawadi, H., Besbess, S., Chidiac, J., Pujade-Lauraine, E. (2012). Endothe- lial protein C receptor expressed by ovarian cancer cells as a possible biomar- ker of cancer onset. International journal of oncology 41, 433-440.

Duesberg, P., Li, R., Fabarius, A., Hehlmann, R. (2006). Aneuploidy and cancer: from correlation to causation. In Infection and inflammation: impacts on oncogenesis (Karger Publishers), pp. 16-44.

Dutta, P., Bui, T., Bauckman, K.A., Keyomarsi, K., Mills, G.B., Nanjundan, M. (2013). EVI1 splice variants modulate functional responses in ovarian cancer cells. Molecular oncology 7, 647-668.

Dwivedi, S.K.D., Mustafi, S.B., Mangala, L.S., Jiang, D., Pradeep, S., Rodriguez-A- guayo, C., Ling, H., Ivan, C., Mukherjee, P., Calin, G.A. (2016). Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotar- get 7, 15093.

Erhard, F., Haas, J., Lieber, D., Malterer, G., Jaskiewicz, L., Zavolan, M., Dölken, L., Zimmer, R. (2014). Widespread context dependency of microRNA-medi- ated regulation. Genome research 24, 906-919.

Erickson, B.K., Conner, M.G., Landen, C.N. (2013). The role of the fallopian tube in the origin of ovarian cancer. American journal of obstetrics and gyneco- logy 209, 409-414.

Fagerberg, L., Hallström, B.M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K. (2014). Analy- sis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular & Cellular Pro- teomics 13, 397-406.

Farooqi, A.A., Qureshi, M.Z., Coskunpinar, E., Naqvi, S., Yaylim, I., Ismail, M. (2014). MiR-421, miR-155 and miR-650: emerging trends of regulation of cancer and apoptosis. Asian Pac J Cancer Prev 15, 1909-1912.

Fekete, T., Rásó, E., Pete, I., Tegze, B., Liko, I., Munkácsy, G., Sipos, N., Rigó, J., Györffy, B. (2012). Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples. Inter- national journal of cancer 131, 95-105.

Filigheddu, N., Gregnanin, I., Porporato, P.E., Surico, D., Perego, B., Galli, L., Pat- rignani, C., Graziani, A., Surico, N. (2010). Differential expression of mic- roRNAs between eutopic and ectopic endometrium in ovarian endometrio- sis. BioMed Research International 2010.

Filipowicz, W., Jaskiewicz, L., Kolb, F.A., Pillai, R.S. (2005). Post-transcriptional gene silencing by siRNAs and miRNAs. Current opinion in structural bio- logy 15, 331-341.

Fishilevich, S., Zimmerman, S., Kohn, A., Stein, T.I., Olender, T., Kolker, E., Saf- ran, M., Lancet, D. (2016). Genic insights from integrated human proteomics in GeneCards. Database 2016, baw030.

Flesken-Nikitin, A., Hwang, C.-I., Cheng, C.-Y., Michurina, T.V., Enikolopov, G., Nikitin, A.Y. (2013). Ovarian surface epithelium at the junction area conta- ins a cancer-prone stem cell niche. Nature 495, 241-245.

Fong, M.Y., McDunn, J., Kakar, S.S. (2011). Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One 6, e19963.

Frampton, A.E., Castellano, L., Colombo, T., Giovannetti, E., Krell, J., Jacob, J., Pellegrino, L., Roca-Alonso, L., Funel, N., Gall, T.M. (2014). MicroRNAs co- operatively inhibit a network of tumor suppressor genes to promote panc- reatic tumor growth and progression. Gastroenterology 146, 268-277. e218.

Gajewski, T.F., Schreiber, H., Fu, Y.-X. (2013). Innate and adaptive immune cells in the tumor microenvironment. Nature immunology 14, 1014-1022.

Gambardella, G., Moretti, M.N., De Cegli, R., Cardone, L., Peron, A., Di Bernar- do, D. (2013). Differential network analysis for the identification of conditi- on-specific pathway activity and regulation. Bioinformatics 29, 1776-1785.

Garcia-Albornoz, M., Thankaswamy-Kosalai, S., Nilsson, A., Väremo, L., Nooka- ew, I., Nielsen, J. (2014). BioMet Toolbox 2.0: genome-wide analysis of meta- bolism and omics data. Nucleic acids research, gku371.

Garg, M., Chaurasiya, D., Rana, R., Jagadish, N., Kanojia, D., Dudha, N., Kamran, N., Salhan, S., Bhatnagar, A., Suri, S. (2007). Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithe- lial ovarian cancer. Clinical Cancer Research 13, 1421-1428.

Gatcliffe, T., Monk, B., Planutis, K., Holcombe, R. (2008). Wnt signaling in ovarian tumorigenesis. International Journal of Gynecological Cancer 18, 954-962.

Gatt, S., Dagan, A. (2012). Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Chemistry and physics of lipids 165, 462-474.

Gautier, L., Cope, L., Bolstad, B.M., Irizarry, R.A. (2004). affy—analysis of Affy- metrix GeneChip data at the probe level. Bioinformatics 20, 307-315.

Gennarino, V.A., D’Angelo, G., Dharmalingam, G., Fernandez, S., Russolillo, G., Sanges, R., Mutarelli, M., Belcastro, V., Ballabio, A., Verde, P. (2012). Iden- tification of microRNA-regulated gene networks by expression analysis of target genes. Genome research 22, 1163-1172.

Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome bio- logy 5, R80.

Gibellini, F., Smith, T.K. (2010). The Kennedy pathway—de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB life 62, 414- 428.

Gill, R., Datta, S., Datta, S. (2014). Differential network analysis in human cancer research. Current pharmaceutical design 20, 4-10.

Glass, K., Quackenbush, J., Spentzos, D., Haibe-Kains, B., Yuan, G.-C. (2015). A network model for angiogenesis in ovarian cancer. BMC bioinformatics 16, 115.

Gloss, B.S., Patterson, K.I., Barton, C.A., Gonzalez, M., Scurry, J.P., Hacker, N.F., Sutherland, R.L., O’Brien, P.M., Clark, S.J. (2012). Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. Cancer letters 318, 76- 85.

Gov, E., Arga, K.Y. (2014). Genetic mutations are characterized by increase in ent- ropy at the transcriptional level. Journal of Biological Systems 22, 377-391.

Gov, E., Arga, K.Y. (2016). Interactive cooperation and hierarchical operation of microRNA and transcription factor crosstalk in human transcriptional regu- latory network. IET Systems Biology 10, 219-228.

Govatati, S., Challa, K., Reddy, S.B., Pramod, K., Deenadayal, M., Chakravarty, B., Shivaji, S., Bhanoori, M. (2015). BRCA1 alterations are associated with en- dometriosis, but BRCA2 alterations show no detectable endometriosis risk: a study in Indian population. Journal of assisted reproduction and genetics 32, 277-285.

Goyama, S., Schibler, J., Cunningham, L., Zhang, Y., Rao, Y., Nishimoto, N., Na- kagawa, M., Olsson, A., Wunderlich, M., Link, K.A. (2013). Transcription fa- ctor RUNX1 promotes survival of acute myeloid leukemia cells. The Journal of clinical investigation 123, 3876-3888.

Grammatikakis, I., Gorospe, M., Abdelmohsen, K. (2013). Modulation of cancer traits by tumor suppressor microRNAs. International journal of molecular sciences 14, 1822-1842.

Grochow, J.A., Kellis, M. (2007). Network motif discovery using subgraph enu- meration and symmetry-breaking. Paper presented at: Annual International Conference on Research in Computational Molecular Biology (Springer).

Groeneweg, J.W., DiGloria, C.M., Yuan, J., Richardson, W.S., Growdon, W.B., Sathyanarayanan, S., Foster, R., Rueda, B.R. (2014a). Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth. Frontiers in oncology 4, 171.

Groeneweg, J.W., Foster, R., Growdon, W.B., Verheijen, R.H., Rueda, B.R. (2014b). Notch signaling in serous ovarian cancer. Journal of ovarian research 7, 95.

Grosswendt, S., Filipchyk, A., Manzano, M., Klironomos, F., Schilling, M., Her- zog, M., Gottwein, E., Rajewsky, N. (2014). Unambiguous identification of miRNA: target site interactions by different types of ligation reactions. Mo- lecular cell 54, 1042-1054.

Gruosso, T., Garnier, C., Abelanet, S., Kieffer, Y., Lemesre, V., Bellanger, D., Bie- che, I., Marangoni, E., Sastre-Garau, X., Mieulet, V. (2015). MAP3K8/TPL- 2/COT is a potential predictive marker for MEK inhibitor treatment in hi- gh-grade serous ovarian carcinomas. Nature communications 6.

Guo, A.-Y., Sun, J., Jia, P., Zhao, Z. (2010). A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC systems biology 4, 10.

Guo, L.M., Pu, Y., Han, Z., Liu, T., Li, Y.X., Liu, M., Li, X., Tang, H. (2009). Mic-

roRNA‐9 inhibits ovarian cancer cell growth through regulation of NF‐κB1. FEBS journal 276, 5537-5546.

Gutman, G., Barak, V., Maslovitz, S., Amit, A., Lessing, J.B., Geva, E. (2008). Re- gulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angi- ogenesis. Fertility and sterility 89, 922-926.

Han, M., Liu, M., Wang, Y., Chen, X., Xu, J., Sun, Y., Zhao, L., Qu, H., Fan, Y., Wu, C. (2012). Antagonism of miR-21 reverses epithelial-mesenchymal transi- tion and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One 7, e39520.

Hanahan, D., Coussens, L.M. (2012). Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer cell 21, 309-322.

Harris, H.R., Cramer, D.W., Vitonis, A.F., DePari, M., Terry, K.L. (2012). Folate, vitamin B6, vitamin B12, methionine and alcohol intake in relation to ovari- an cancer risk. International journal of cancer 131, E518-E529.

Harris, S.L., Levine, A.J. (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908.

Hata, K., Dhar, D.K., Watanabe, Y., Nakai, H., Hoshiai, H. (2007). Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. European Journal of Cancer 43, 1452-1459.

Hatakeyama, S. (2011). TRIM proteins and cancer. Nature Reviews Cancer 11, 792-804.

Hayat, M. (2016). Autophagy: Cancer, Other Pathologies, Inflammation, Immu- nity, Infection, and Aging: Volume 9: Human Diseases and Autophagosome (Academic Press).

Hayes, J., Peruzzi, P.P., Lawler, S. (2014). MicroRNAs in cancer: biomarkers, func- tions and therapy. Trends in molecular medicine 20, 460-469.

He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G.A., Liu, C.-g., Franssila, K., Suster, S. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102, 19075-19080.

He, J., Jing, Y., Li, W., Qian, X., Xu, Q., Li, F.-S., Liu, L.-Z., Jiang, B.-H., Jiang, Y. (2013). Roles and mechanism of miR-199a and miR-125b in tumor angioge- nesis. PLoS One 8, e56647.

He, L., He, X., Lim, L.P., De Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134.

Heo, J.H., Song, J.-y., Jeong, J.-y., Kim, G., Kim, T.H., Kang, H., Kwon, A.-y., An, H.J. (2016). Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer. Journal of clinical pathology 69, 109-116.

Hever, A., Roth, R.B., Hevezi, P., Marin, M.E., Acosta, J.A., Acosta, H., Rojas, J., Herrera, R., Grigoriadis, D., White, E. (2007). Human endometriosis is as- sociated with plasma cells and overexpression of B lymphocyte stimulator. Proceedings of the National Academy of Sciences 104, 12451-12456.

Hippisley-Cox, J., Coupland, C. (2012). Identifying women with suspected ovari- an cancer in primary care: derivation and validation of algorithm. Bmj 344, d8009.

Hira, S., Tomita, T., Matsui, T., Igarashi, K., Ikeda‐Saito, M. (2007). Bach1, a heme‐dependent transcription factor, reveals presence of multiple heme binding sites with distinct coordination structure. IUBMB life 59, 542-551.

Hobert, O. (2008). Gene regulation by transcription factors and microRNAs. Science 319, 1785-1786.

Hornstein, E., Shomron, N. (2006). Canalization of development by microRNAs. Nature genetics 38, S20-S24.

Hsiao, T.-H., Chiu, Y.-C., Hsu, P.-Y., Lu, T.-P., Lai, L.-C., Tsai, M.-H., Huang,

T.H.-M., Chuang, E.Y., Chen, Y. (2016). Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancers. Scientific reports 6.

Hsu, C.-L., Juan, H.-F., Huang, H.-C. (2015). Functional analysis and characteri- zation of differential coexpression networks. Scientific reports 5, 13295.

Huang, D.W., Sherman, B.T., Lempicki, R.A. (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37, 1-13.

Huang, Y., Shen, X.J., Zou, Q., Wang, S.P., Tang, S.M., Zhang, G.Z. (2011). Bio- logical functions of microRNAs: a review. Journal of physiology and bioche- mistry 67, 129-139.

Huang, Y.-W., Chen, C., Xu, M.-M., Li, J.-D., Xiao, J., Zhu, X.-F. (2013). Expressi-

on of c-Src and phospho-Src in epithelial ovarian carcinoma. Molecular and cellular biochemistry 376, 73-79.

Huff, L.P., DeCristo, M.J., Trembath, D., Kuan, P.F., Yim, M., Liu, J., Cook, D.R., Miller, C.R., Der, C.J., Cox, A.D. (2013). The role of Ect2 nuclear RhoGEF activity in ovarian cancer cell transformation. Genes & cancer 4, 460-475.

Ideker, T., Krogan, N.J. (2012). Differential network biology. Molecular systems biology 8, 565.

Iorio, E., Ricci, A., Bagnoli, M., Pisanu, M.E., Castellano, G., Di Vito, M., Ventu- rini, E., Glunde, K., Bhujwalla, Z.M., Mezzanzanica, D. (2010). Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer research 70, 2126-2135.

Iorio, M.V., Croce, C.M. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO molecular medicine 4, 143-159.

Iorio, M.V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.-G., Alder, H. (2007). MicroRNA signatures in human ovarian cancer. Cancer research 67, 8699-8707.

Iozzo, R.V., Sanderson, R.D. (2011). Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. Journal of cellular and molecular me- dicine 15, 1013-1031.

Iwanaga, R., Komori, H., Ishida, S., Okamura, N., Nakayama, K., Nakayama, K., Ohtani, K. (2006). Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners. Oncogene 25, 1786-1798.

Jensen, L.E., Whitehead, A.S. (2003). Ubiquitin activated tumor necrosis factor receptor associated factor‐6 (TRAF6) is recycled via deubiquitination. FEBS letters 553, 190-194.

Jiang, L., Huang, J., Li, L., Chen, Y., Chen, X., Zhao, X., Yang, D. (2015). Mic- roRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. The Journal of Clinical Endocri- nology & Metabolism 100, E729-E738.

Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., Li, M., Wang, G., Liu, Y. (2009). miR2Disease: a manually curated database for microRNA deregula- tion in human disease. Nucleic acids research 37, D98-D104.

Jin, K.L., Pak, J.H., Park, J.-Y., Choi, W.H., Lee, J.-Y., Kim, J.-H., Nam, J.-H. (2008).

Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissu- es. Journal of gynecologic oncology 19, 185-190.

Jin, N., Wu, H., Miao, Z., Huang, Y., Hu, Y., Bi, X., Wu, D., Qian, K., Wang, L.,

Wang, C. (2015). Network-based survival-associated module biomarker and its crosstalk with cell death genes in ovarian cancer. Scientific reports 5.

Johansson, J., Stener-Victorin, E. (2013). Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evidence-Based Complementary and Alternative Medicine 2013.

Joshi, H.P., Subramanian, I.V., Schnettler, E.K., Ghosh, G., Rupaimoole, R., Evans, C., Saluja, M., Jing, Y., Cristina, I., Roy, S. (2014). Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovari- an cancer metastasis. Proceedings of the National Academy of Sciences 111, 5331-5336.

Ju, W., Yoo, B.C., Kim, I.-J., Kim, J.W., Kim, S.C., Lee, H.P. (2009). Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays. Oncology Research Featu- ring Preclinical and Clinical Cancer Therapeutics 18, 47-56.

Kamburov, A., Grossmann, A., Herwig, R., Stelzl, U. (2012). Cluster-based as- sessment of protein-protein interaction confidence. BMC bioinformatics 13, 262.

Kan, C.W., Hahn, M.A., Gard, G.B., Maidens, J., Huh, J.Y., Marsh, D.J., Howell, V.M. (2012). Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC cancer 12, 627.

Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., Tanabe, M. (2014). Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic acids research 42, D199-D205.

Karagoz, K., L Lehman, H., B Stairs, D., Sinha, R., Y Arga, K. (2016a). Proteomic and metabolic signatures of esophageal squamous cell carcinoma. Current cancer drug targets 16, 721-736.

Karagoz, K., Sevimoglu, T., Arga, K.Y. (2016b). Integration of multiple biological features yields high confidence human protein interactome. Journal of theo- retical biology 403, 85-96.

Karagoz, K., Sinha, R., Arga, K.Y. (2015). Triple negative breast cancer: a multi-o- mics network discovery strategy for candidate targets and driving pathways. Omics: a journal of integrative biology 19, 115-130.

Kau, T.R., Way, J.C., Silver, P.A. (2004). Nuclear transport and cancer: from mec- hanism to intervention. Nature Reviews Cancer 4, 106-117.

Ke, C., Hou, Y., Zhang, H., Fan, L., Ge, T., Guo, B., Zhang, F., Yang, K., Wang, J., Lou, G. (2015). Large‐scale profiling of metabolic dysregulation in ovarian cancer. International journal of cancer 136, 516-526.

Kenigsberg, S., Bentov, Y., Chalifa-Caspi, V., Potashnik, G., Ofir, R., Birk, O.S. (2009). Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Molecular human reproduction.

Khamas, A., Ishikawa, T., Shimokawa, K., Mogushi, K., Iida, S., Ishiguro, M., Mizushima, H., Tanaka, H., Uetake, H., Sugihara, K. (2012). Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2’-deoxycyti- dine, microarray and gene expression profile. Cancer Genomics-Proteomics 9, 67-75.

Kim, J.-E., Billadeau, D.D., Chen, J. (2005). The tandem BRCT domains of Ect2 are required for both negative and positive regulation of Ect2 in cytokinesis. Journal of Biological Chemistry 280, 5733-5739.

King, E.R., Tung, C.S., Tsang, Y.T., Zu, Z., Lok, G.T., Deavers, M.T., Malpica, A., Wolf, J.K., Lu, K.H., Birrer, M.J. (2011). The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian can- cer. The American journal of surgical pathology 35, 904.

Klemm, F., Joyce, J.A. (2015). Microenvironmental regulation of therapeutic response in cancer. Trends in cell biology 25, 198-213.

Ko, S.Y., Barengo, N., Ladanyi, A., Lee, J.-S., Marini, F., Lengyel, E., Naora, H. (2012). HOXA9 promotes ovarian cancer growth by stimulating cancer-as- sociated fibroblasts. The Journal of clinical investigation 122, 3603-3617.

Komatsu, K., Nakanishi, Y., Nemoto, N., Hori, T., Sawada, T., Kobayashi, M. (2004). Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas. Brain tumor pathology 21, 105-112.

Komiyama, S., Kurahashi, T., Ishikawa, M., Tanaka, K., Komiyama, M., Mikami, M., Udagawa, Y. (2011). Expression of TGFßl and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/car- boplatin. Oncology reports 25, 1131.

Kori, M., Gov, E., Arga, K.Y. (2016). Molecular signatures of ovarian diseases: In- sights from network medicine perspective. Systems Biology in Reproductive Medicine 62, 266-282.

Korpal, M., Lee, E.S., Hu, G., Kang, Y. (2008). The miR-200 family inhibits epithe- lial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Journal of Biological Chemistry 283, 14910-14914.

Koti, M., Gooding, R.J., Nuin, P., Haslehurst, A., Crane, C., Weberpals, J., Chil- ds, T., Bryson, P., Dharsee, M., Evans, K. (2013). Identification of the IGF1/ PI3K/NF κ B/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer. BMC cancer 13, 549.

Kubiczkova, L., Sedlarikova, L., Hajek, R., Sevcikova, S. (2012). TGF-β–an excel- lent servant but a bad master. Journal of translational medicine 10, 183.

Kulbe, H., Chakravarty, P., Leinster, D.A., Charles, K.A., Kwong, J., Thompson, R.G., Coward, J.I., Schioppa, T., Robinson, S.C., Gallagher, W.M. (2012). A dynamic inflammatory cytokine network in the human ovarian cancer mic- roenvironment. Cancer research 72, 66-75.

Lachej, N., Didžiapetrienė, J., Kazbarienė, B., Kanopienė, D., Jonušienė, V. (2013). Association between Notch signaling pathway and cancer. Acta medica Li- tuanica 19.

Lamarre, S.G., Morrow, G., Macmillan, L., Brosnan, M.E., Brosnan, J.T. (2013). Formate: an essential metabolite, a biomarker, or more? Clinical chemistry and laboratory medicine 51, 571-578.

Lau, T., Chan, L.K., Wong, E.C., Hui, C.W., Sneddon, K., Cheung, T., Yim, S., Lee, J.H., Yeung, C.S., Chung, T.K. (2017). A loop of cancer-stroma-cancer intera- ction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-E- GFR. Oncogene.

Laudanski, P., Charkiewicz, R., Kuzmicki, M., Szamatowicz, J., Charkiewicz, A., Niklinski, J. (2013). MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis. Reproductive Biology and Endocrinology 11, 78.

Lawrenson, K., Grun, B., Lee, N., Mhawech‐Fauceglia, P., Kan, J., Swenson, S., Lin, Y.G., Pejovic, T., Millstein, J., Gayther, S.A. (2015). NPPB is a novel candidate biomarker expressed by cancer‐associated fibroblasts in epithelial ovarian cancer. International journal of cancer 136, 1390-1401.

Le Page, C., Ouellet, V., Quinn, M.C., Tonin, P.N., Provencher, D.M., Mes-Mas- son, A.-M. (2008). BTF4/BTNA3. 2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer. Cancer Epidemiology and Prevention Biomarkers 17, 913-920.

Le, T.D., Liu, L., Liu, B., Tsykin, A., Goodall, G.J., Satou, K., Li, J. (2013). Inferring microRNA and transcription factor regulatory networks in heterogeneous data. BMC bioinformatics 14, 92.

Leary, A., Auclin, E., Pautier, P., Lhommé, C. (2013). The PI3K/Akt/mTOR pat- hway in ovarian cancer: biological rationale and therapeutic opportunities. Ovarian cancer-a clinical and translational update Croatia: InTech, 275-302.

Lecca, P., Re, A. (2015). Detecting modules in biological networks by edge weight clustering and entropy significance. Frontiers in genetics 6, 265.

Lei, Y.-Y., Wang, W.-J., Mei, J.-H., Wang, C.-L. (2014). Mitogen-activated prote- in kinase signal transduction in solid tumors. Asian Pac J Cancer Prev 15, 8539-8548.

Lewis, B.P., Shih, I.-h., Jones-Rhoades, M.W., Bartel, D.P., Burge, C.B. (2003). Pre- diction of mammalian microRNA targets. Cell 115, 787-798.

Li, B.-Q., Huang, T., Liu, L., Cai, Y.-D., Chou, K.-C. (2012). Identification of colo- rectal cancer related genes with mRMR and shortest path in protein-protein interaction network. PLoS One 7, e33393.

Li, F., Wang, H., Feng, X., Li, P., Shu, T., Zhao, X., Li, B. (2016). Expression and cli- nical significance of ELOVL6 gene in high-grade serous ovarian carcinoma. Zhonghua fu chan ke za zhi 51, 192-197.

Li, H., Xie, S., Liu, M., Chen, Z., Liu, X., Wang, L., Li, D., Zhou, Y. (2014a). The cli- nical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155- 5p and mir-335-5p in gastric cancer tumorigenesis. International journal of oncology 45, 197-208.

Li, H., Zeng, J., Shen, K. (2014b). PI3K/AKT/mTOR signaling pathway as a thera- peutic target for ovarian cancer. Archives of gynecology and obstetrics 290, 1067-1078.

Li, M., Balch, C., Montgomery, J.S., Jeong, M., Chung, J.H., Yan, P., Huang, T.H., Kim, S., Nephew, K.P. (2009). Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC medical genomics 2, 34.

Liang, C., Li, Y., Luo, J., Zhang, Z. (2015). A novel motif-discovery algorithm to identify co-regulatory motifs in large transcription factor and microRNA co-regulatory networks in human. Bioinformatics 31, 2348-2355.

Lili, L.N., Matyunina, L.V., Walker, L., Benigno, B.B., McDonald, J.F. (2013). Mo- lecular profiling predicts the existence of two functionally distinct classes of ovarian cancer stroma. BioMed research international 2013.

Lin, C.-C., Chen, Y.-J., Chen, C.-Y., Oyang, Y.-J., Juan, H.-F., Huang, H.-C. (2012).

Crosstalk between transcription factors and microRNAs in human protein interaction network. BMC systems biology 6, 18.

Lin, Y., Cui, M., Shi, Y., Wang, F., Wang, Q., Teng, H. (2011). Increased COX-2 expression in patients with ovarian cancer. African Journal of Biotechnology 10, 15040-15043.

Liu, E.T., Lauffenburger, D.A. (2009). Systems biomedicine: concepts and perspe- ctives (Academic Press).

Liu, N., Williams, A.H., Kim, Y., McAnally, J., Bezprozvannaya, S., Sutherland, L.B., Richardson, J.A., Bassel-Duby, R., Olson, E.N. (2007). An intragenic MEF2-dependent enhancer directs muscle-specific expression of mic- roRNAs 1 and 133. Proceedings of the National Academy of Sciences 104, 20844-20849.

Liu, S., Zhang, X., Shi, C., Lin, J., Chen, G., Wu, B., Wu, L., Shi, H., Yuan, Y., Zhou,

W. (2015a). Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome. Journal of translational medicine 13, 238.

Liu, Z.-P., Wu, C., Miao, H., Wu, H. (2015b). RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database 2015, bav095.

Llauradó, M., Abal, M., Castellví, J., Cabrera, S., Gil‐Moreno, A., Pérez‐Benaven- te, A., Colás, E., Doll, A., Dolcet, X., Matias‐Guiu, X. (2012). ETV5 transcrip- tion factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells. International journal of cancer 130, 1532-1543.

Llauradó, M., Abal, M., Castellví, J., Cabrera, S., Gil‐Moreno, A., Pérez‐Benaven- te, A., Colás, E., Doll, A., Dolcet, X., Matias‐Guiu, X. (2012). ETV5 transcrip- tion factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells. International journal of cancer 130, 1532-1543.

López, Y., Nakai, K., Patil, A. (2015). HitPredict version 4: comprehensive relia- bility scoring of physical protein–protein interactions from more than 100 species. Database: the journal of biological databases and curation 2015.

Lu, G., Zhang, Q., Huang, Y., Song, J., Tomaino, R., Ehrenberger, T., Lim, E., Liu, W., Bronson, R.T., Bowden, M. (2014). Phosphorylation of ETS1 by Src fa- mily kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell 26, 222-234.

Lu, T.-P., Tsai, M.-H., Lee, J.-M., Hsu, C.-P., Chen, P.-C., Lin, C.-W., Shih, J.-Y.,

Yang, P.-C., Hsiao, C.K., Lai, L.-C. (2010). Identification of a novel biomarker SEMA5A for non-small cell lung carcinoma in non-smoking women. Can- cer Epidemiology and Prevention Biomarkers, cebp. 0332.2010.

Luvero, D., Milani, A., Ledermann, J.A. (2014). Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. Therapeutic advances in medical oncology 6, 229-239.

Ma, R., Ye, X., Cheng, H., Ma, Y., Cui, H., Chang, X. (2015). PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Gynecologic oncology 137, 546-552.

Ma, Y., Ren, Y., Zhang, X., Lin, L., Liu, Y., Rong, F., Wen, W., Li, F. (2014). High

GOLPH3 expression is associated with a more aggressive behavior of epithe- lial ovarian carcinoma. Virchows Archiv 464, 443-452.

MacDonald, B.T., Tamai, K., He, X. (2009). Wnt/β-catenin signaling: compo- nents, mechanisms, and diseases. Developmental cell 17, 9-26.

Maiuri, M.C., Kroemer, G. (2015). Essential role for oxidative phosphorylation in cancer progression. Cell metabolism 21, 11-12.

Mangan, S., Alon, U. (2003). Structure and function of the feed-forward loop network motif. Proceedings of the National Academy of Sciences 100, 11980-11985.

Manna, P.R., Stocco, D.M. (2011). The role of specific mitogen-activated protein kinase signaling cascades in the regulation of steroidogenesis. Journal of sig- nal transduction 2011.

Marchitti, S.A., Deitrich, R.A., Vasiliou, V. (2007). Neurotoxicity and metabo- lism of the catecholamine-derived 3, 4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacological reviews 59, 125-150.

Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., Walley, A.J., Froguel, P., Carlsson, L.M., Uhlen, M. (2013). Integration of cli- nical data with a genome‐scale metabolic model of the human adipocyte. Molecular systems biology 9, 649.

Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., Nielsen, J. (2014). Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nature communications 5.

Martinez, N.J., Walhout, A.J. (2009). The interplay between transcription factors and microRNAs in genome‐scale regulatory networks. Bioessays 31, 435- 445.

McCubrey, J.A., Steelman, L.S., Chappell, W.H., Abrams, S.L., Wong, E.W., Chang, F., Lehmann, B., Terrian, D.M., Milella, M., Tafuri, A. (2007). Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773, 1263-1284.

McDonald, J., Bowen, N.J., Wang, L. (2014). MIR-200 family induces mesenchy- mal-to-epithelial transition (MET) in ovarian cancer cells (Google Patents). McMahon, H.T., Boucrot, E. (2011). Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nature reviews Molecular cell biology 12, 517-533.

Mercer, T.R., Mattick, J.S. (2013). Understanding the regulatory and transcrip- tional complexity of the genome through structure. Genome research 23, 1081-1088.

Merritt, M.A., Parsons, P.G., Newton, T.R., Martyn, A.C., Webb, P.M., Green, A.C., Papadimos, D.J., Boyle, G.M. (2009). Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer. BMC cancer 9, 378.

Miles, L., Miles, M.V., Tang, P.H., Horn, P.S., Quinlan, J.G., Wong, B., Wenisch, A., Bove, K.E. (2005). Ubiquinol: a potential biomarker for tissue energy requi- rements and oxidative stress. Clinica chimica acta 360, 87-96.

Mills, E., O’Neill, L.A. (2014). Succinate: a metabolic signal in inflammation. Trends in cell biology 24, 313-320.

Milne, K., Köbel, M., Kalloger, S.E., Barnes, R.O., Gao, D., Gilks, C.B., Watson, P.H., Nelson, B.H. (2013). Correction: Systematic Analysis of Immune Infilt- rates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors. PLoS One 8.

Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., Alon, U. (2002). Network motifs: simple building blocks of complex networks. Science 298, 824-827.

Mirzayans, R., Andrais, B., Scott, A., Murray, D. (2012). New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. BioMed Research International 2012.

Mitchell, T.J., John, S. (2005). Signal transducer and activator of transcription (STAT) signalling and T‐cell lymphomas. Immunology 114, 301-312.

Mitra, A.K., Zillhardt, M., Hua, Y., Tiwari, P., Murmann, A.E., Peter, M.E., Leng- yel, E. (2012). MicroRNAs reprogram normal fibroblasts into cancer-associ- ated fibroblasts in ovarian cancer. Cancer discovery 2, 1100-1108.

Mok, S.C., Bonome, T., Vathipadiekal, V., Bell, A., Johnson, M.E., Park, D.-C., Hao, K., Yip, D.K., Donninger, H., Ozbun, L. (2009). A gene signature pre- dictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer cell 16, 521-532.

Moreno, C.S., Matyunina, L., Dickerson, E.B., Schubert, N., Bowen, N.J., Loga- ni, S., Benigno, B.B., McDonald, J.F. (2007). Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. PLoS One 2, e441.

Morone, S., Lo-Buono, N., Parrotta, R., Giacomino, A., Nacci, G., Brusco, A., La- rionov, A., Ostano, P., Mello-Grand, M., Chiorino, G. (2012). Overexpressi- on of CD157 contributes to epithelial ovarian cancer progression by promo- ting mesenchymal differentiation. PLoS One 7, e43649.

Mostowska, A., Pawlik, P., Sajdak, S., Markowska, J., Pawałowska, M., Lianeri, M., Jagodzinski, P.P. (2014). An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population. Molecular diagnosis & therapy 18, 85-91.

Moustakas, A., Pardali, K., Gaal, A., Heldin, C.-H. (2002). Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunology let- ters 82, 85-91.

Mu, L., Zheng, W., Wang, L., Chen, X., Yang, J. (2008). Focal adhesion kinase expression in ovarian endometriosis. International Journal of Gynecology & Obstetrics 101, 161-165.

Muller, P.A., Vousden, K.H. (2014). Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer cell 25, 304-317.

Munoz-Pinedo, C., El Mjiyad, N., Ricci, J. (2012). Cancer metabolism: current perspectives and future directions. Cell death & disease 3, e248.

Nagaraj, N.S., Datta, P.K. (2010). Targeting the transforming growth factor-β sig- naling pathway in human cancer. Expert opinion on investigational drugs 19, 77-91.

Nahum, G.G., Kaunitz, A.M., Rosen, K., Schmelter, T., Lynen, R. (2015). Ovarian cysts: presence and persistence with use of a 13.5 mg levonorgestrel-releasing intrauterine system. Contraception 91, 412-417.

Nam, E.J., Lee, M., Yim, G.W., Kim, J.H., Kim, S., Kim, S.W., Kim, Y.T. (2012).

MicroRNA profiling of a CD133+ spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. BMC medical genomics 5, 18.

Neuberg, S.L., Kenrick, D.T., Schaller, M. (2011). Human threat management sys- tems: Self-protection and disease avoidance. Neuroscience & Biobehavioral Reviews 35, 1042-1051.

Ni, I.B.P., Zakaria, Z., Muhammad, R., Abdullah, N., Ibrahim, N., Emran, N.A., Abdullah, N.H., Hussain, S.N.A.S. (2010). Gene expression patterns distin-guish breast carcinomas from normal breast tissues: the Malaysian context. Pathology-Research and Practice 206, 223-228.

Nicholas, M.K., Lukas, R.V., Jafri, N.F., Faoro, L., Salgia, R. (2006). Epidermal growth factor receptor–mediated signal transduction in the development and therapy of gliomas. Clinical Cancer Research 12, 7261-7270.

Nishikawa, N., Toyota, M., Suzuki, H., Honma, T., Fujikane, T., Ohmura, T., Nis- hidate, T., Ohe-Toyota, M., Maruyama, R., Sonoda, T. (2007). Gene ampli- fication and overexpression of PRDM14 in breast cancers. Cancer research 67, 9649-9657.

Ntziachristos, P., Lim, J.S., Sage, J., Aifantis, I. (2014). From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer cell 25, 318-334.

Nyman, D.W., Stratton, M.S., Kopplin, M.J., Dalkin, B.L., Nagle, R.B., Gandolfi, A.J. (2004). Selenium and selenomethionine levels in prostate cancer pa- tients. Cancer detection and prevention 28, 8-16.

Oksuz, Z., Serin, M.S., Kaplan, E., Dogen, A., Tezcan, S., Aslan, G., Emekdas, G., Sezgin, O., Altintas, E., Tiftik, E.N. (2015). Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-inva- sive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Molecular biology reports 42, 713-720.

Oksvold, M.P., Skarpen, E., Lindeman, B., Roos, N., Huitfeldt, H.S. (2000). Im- munocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells. Journal of Histochemistry & Cytochemistry 48, 21-33.

Ortega, I., Duleba, A.J. (2014). Role of Statins in PCOS Management. In Polycys- tic Ovary Syndrome (Springer), pp. 181-203.

Pamuła-Piłat, J., Rubel, T., Rzepecka, I., Olbryt, M., Herok, R., Dansonka-Miesz- kowska, A., Grzybowska, E., Kupryjańczyk, J. (2013). Gene expression pro- files in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas. Journal of biological regulators and homeostatic agents 28, 659- 674.

Panda, H., Pelakh, L., Chuang, T.-D., Luo, X., Bukulmez, O., Chegini, N. (2012). Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reproductive sciences 19, 786-796.

Papadatos-Pastos, D., Dedes, K.J., de Bono, J.S., Kaye, S.B. (2011). Revisiting the role of antiandrogen strategies in ovarian cancer. The oncologist 16, 1413- 1421.

Patil, K.R., Nielsen, J. (2005). Uncovering transcriptional regulation of metabo- lism by using metabolic network topology. Proc Natl Acad Sci U S A 102, 2685-2689.

Paulsson, J., Micke, P. (2014). Prognostic relevance of cancer-associated fibrob- lasts in human cancer. Paper presented at: Seminars in cancer biology (El- sevier).

Pavone, M.E., Lyttle, B.M. (2015). Endometriosis and ovarian cancer: links, risks, and challenges faced. International journal of women’s health 7, 663.

Peng, D.-X., Luo, M., Qiu, L.-W., He, Y.-L., Wang, X.-F. (2012). Prognostic impli- cations of microRNA-100 and its functional roles in human epithelial ovari- an cancer. Oncology reports 27, 1238-1244.

Persico, M., Ceol, A., Gavrila, C., Hoffmann, R., Florio, A., Cesareni, G. (2005). HomoMINT: an inferred human network based on orthology mapping of protein interactions discovered in model organisms. BMC bioinformatics 6, S21.

Petersen, C.P., Bordeleau, M.-E., Pelletier, J., Sharp, P.A. (2006). Short RNAs rep- ress translation after initiation in mammalian cells. Molecular cell 21, 533- 542.

Pfister, T.D., Reinhold, W.C., Agama, K., Gupta, S., Khin, S.A., Kinders, R.J., Par- chment, R.E., Tomaszewski, J.E., Doroshow, J.H., Pommier, Y. (2009). Topo- isomerase I levels in the NCI-60 cancer cell line panel determined by valida- ted ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Molecular cancer therapeutics 8, 1878-1884.

Pils, D., Bachmayr-Heyda, A., Auer, K., Svoboda, M., Auner, V., Hager, G., Ober- mayr, E., Reiner, A., Reinthaller, A., Speiser, P. (2014). Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients–A study of the OVCAD consortium. European journal of cancer 50, 99-110.

Pink, R.C., Samuel, P., Massa, D., Caley, D.P., Brooks, S.A., Carter, D.R.F. (2015). The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistan- ce in ovarian cancer cells. Gynecologic oncology 137, 143-151.

Plotnik, J.P., Budka, J.A., Ferris, M.W., Hollenhorst, P.C. (2014). ETS1 is a ge- nome-wide effector of RAS/ERK signaling in epithelial cells. Nucleic acids research 42, 11928-11940.

Pópulo, H., Lopes, J.M., Soares, P. (2012). The mTOR signalling pathway in hu- man cancer. International journal of molecular sciences 13, 1886-1918.

Porta, C., Paglino, C., Mosca, A. (2014). Targeting PI3K/Akt/mTOR signaling in cancer. Targeting PI3K/mTOR signaling in cancer, 47.

Portales-Casamar, E., Arenillas, D., Lim, J., Swanson, M.I., Jiang, S., McCallum, A., Kirov, S., Wasserman, W.W. (2009). The PAZAR database of gene regu- latory information coupled to the ORCA toolkit for the study of regulatory sequences. Nucleic acids research 37, D54-D60.

Pralhada Rao, R., Vaidyanathan, N., Rengasamy, M., Mammen Oommen, A., So- maiya, N., Jagannath, M. (2013). Sphingolipid metabolic pathway: an over- view of major roles played in human diseases. Journal of lipids 2013.

Prasad, T.K., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S., Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, B., Venugopal, A. (2009). Human pro- tein reference database—2009 update. Nucleic acids research 37, D767-D772.

Prat, J. (2014). Staging classification for cancer of the ovary, fallopian tube, and peritoneum. International Journal of Gynecology & Obstetrics 124, 1-5.

Pundir, C.S., Devi, R. (2014). Biosensing methods for xanthine determination: A review. Enzyme and microbial technology 57, 55-62.

Qiu, C., Wang, J., Yao, P., Wang, E., Cui, Q. (2010). microRNA evolution in a hu- man transcription factor and microRNA regulatory network. BMC systems biology 4, 90.

Quail, D.F., Joyce, J.A. (2013). Microenvironmental regulation of tumor progres- sion and metastasis. Nature medicine 19, 1423-1437.

Ravichandran, K.S. (2001). Signaling via Shc family adapter proteins. Oncogene 20, 6322.

Richards, J.S., Pangas, S.A. (2010). The ovary: basic biology and clinical implicati- ons. The Journal of clinical investigation 120, 963-972.

Ritchie, W., Granjeaud, S., Puthier, D., Gautheret, D. (2008). Entropy measures quantify global splicing disorders in cancer. PLoS Comput Biol 4, e1000011. Ross, D.T., Scherf, U., Eisen, M.B., Perou, C.M., Rees, C., Spellman, P., Iyer, V., Jef- frey, S.S., Van de Rijn, M., Waltham, M. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nature genetics 24, 227-235.

Sampson, J.A. (1925). Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Archives of Surgery 10, 1-72.

Sayasneh, A., Tsivos, D., Crawford, R. (2011). Endometriosis and ovarian cancer: a systematic review. ISRN obstetrics and gynecology 2011.

Schaefer, M.H., Fontaine, J.-F., Vinayagam, A., Porras, P., Wanker, E.E., Andra- de-Navarro, M.A. (2012). HIPPIE: Integrating protein interaction networks with experiment based quality scores. PLoS One 7, e31826.

Schauer, I.G., Sood, A.K., Mok, S., Liu, J. (2011). Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epit- helial ovarian cancer. Neoplasia 13, 393-405.

Scotto, L., Narayan, G., Nandula, S.V., Arias‐Pulido, H., Subramaniyam, S., Schneider, A., Kaufmann, A.M., Wright, J.D., Pothuri, B., Mansukhani, M. (2008). Identification of copy number gain and overexpressed genes on ch- romosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes, Chromosomes and Cancer 47, 755-765. Sedlák, E., Fabian, M., Robinson, N.C., Musatov, A. (2010). Ferricytochrome c protects mitochondrial cytochrome c oxidase against hydrogen peroxide-in- duced oxidative damage. Free Radical Biology and Medicine 49, 1574-1581.

Sengupta, D., Bandyopadhyay, S. (2013). Topological patterns in microRNA–gene regulatory network: studies in colorectal and breast cancer. Molecular bi- oSystems 9, 1360-1371.

Sevimoglu, T., Arga, K.Y. (2014). The role of protein interaction networks in sys- tems biomedicine. Computational and structural biotechnology journal 11, 22-27.

Sevimoglu, T., Arga, K.Y. (2015). Computational systems biology of psoriasis: Are we ready for the age of omics and systems biomarkers? Omics: a journal of integrative biology 19, 669-687.

Shahab, S.W., Matyunina, L.V., Mezencev, R., Walker, L.D., Bowen, N.J., Benigno, B.B., McDonald, J.F. (2011). Evidence for the complexity of microRNA-me- diated regulation in ovarian cancer: a systems approach. PLoS One 6, e22508.

Shalgi, R., Lieber, D., Oren, M., Pilpel, Y. (2007). Global and local architecture of the mammalian microRNA–transcription factor regulatory network. PLoS Comput Biol 3, e131.

Shen-Orr, S.S., Milo, R., Mangan, S., Alon, U. (2002). Network motifs in the transcriptional regulation network of Escherichia coli. Nature genetics 31, 64-68.

Shenouda, S.K., Alahari, S.K. (2009). MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer and Metastasis Reviews 28, 369.

Shi, Y., Massagué, J. (2003). Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700.

Shields, B.B., Pecot, C.V., Gao, H., McMillan, E., Potts, M., Nagel, C., Purinton, S., Wang, Y., Ivan, C., Kim, H.S. (2015). A genome‐scale screen reveals context‐ dependent ovarian cancer sensitivity to miRNA overexpression. Molecular systems biology 11, 842.

Shlomi, T., Cabili, M.N., Herrgård, M.J., Palsson, B.Ø., Ruppin, E. (2008). Network-based prediction of human tissue-specific metabolism. Nature bi- otechnology 26, 1003-1010.

Siegel, R.L., Miller, K.D., Jemal, A. (2016). Cancer statistics, 2016. CA: a cancer journal for clinicians 66, 7-30.

Signorile, P.G., Baldi, A. (2015). New evidence in endometriosis. The internatio- nal journal of biochemistry & cell biology 60, 19-22.

Simoens, S., Hummelshoj, L., D’Hooghe, T. (2007). Endometriosis: cost estimates and methodological perspective. Human reproduction update 13, 395-404.

Sims, A., Zweemer, A.J., Nagumo, Y., Faratian, D., Muir, M., Dodds, M., Um, I., Kay, C., Hasmann, M., Harrison, D. (2012). Defining the molecular respon- se to trastuzumab, pertuzumab and combination therapy in ovarian cancer. British journal of cancer 106, 1779-1789.

Siu, K.T., Rosner, M.R., Minella, A.C. (2012). An integrated view of cyclin E fun- ction and regulation. Cell cycle 11, 57-64.

Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.-L., Ideker, T. (2011). Cytoscape 2.8: new features for data integration and network visualization. Bioinforma- tics 27, 431-432.

Smyth, G.K., Ritchie, M., Thorne, N., Wettenhall, J. (2005). LIMMA: linear mo- dels for microarray data. In Bioinformatics and Computational Biology So- lutions Using R and Bioconductor. Statistics for Biology and Health.

Solomon, D.A., Kim, T., Diaz-Martinez, L.A., Fair, J., Elkahloun, A.G., Harris, B.T., Toretsky, J.A., Rosenberg, S.A., Shukla, N., Ladanyi, M. (2011). Muta- tional inactivation of STAG2 causes aneuploidy in human cancer. Science 333, 1039-1043.

Sørensen, A.E., Wissing, M.L., Salö, S., Englund, A.L.M., Dalgaard, L.T. (2014). MicroRNAs related to polycystic ovary syndrome (PCOS). Genes 5, 684-708. Sourbier, C., Ricketts, C.J., Matsumoto, S., Crooks, D.R., Liao, P.-J., Mannes, P.Z., Yang, Y., Wei, M.-H., Srivastava, G., Ghosh, S. (2014). Targeting ABL1-me- diated oxidative stress adaptation in fumarate hydratase-deficient cancer.

Cancer Cell 26, 840-850.

Spillman, M.A., Manning, N.G., Dye, W.W., Sartorius, C.A., Post, M.D., Harrell, J.C., Jacobsen, B.M., Horwitz, K.B. (2010). Tissue-specific pathways for est- rogen regulation of ovarian cancer growth and metastasis. Cancer research 70, 8927-8936.

Stegh, A.H. (2012). Targeting the p53 signaling pathway in cancer therapy–the promises, challenges and perils. Expert opinion on therapeutic targets 16, 67-83.

Stevens, V.L., McCullough, M.L., Pavluck, A.L., Talbot, J.T., Feigelson, H.S., Thun, M.J., Calle, E.E. (2007). Association of polymorphisms in one-carbon meta- bolism genes and postmenopausal breast cancer incidence. Cancer Epidemi- ology and Prevention Biomarkers 16, 1140-1147.

Stoppa-Lyonnet, D. (2016). The biological effects and clinical implications of BRCA mutations: where do we go from here? European Journal of Human Genetics 24, S3-S9.

Stuart, J.M., Segal, E., Koller, D., Kim, S.K. (2003). A gene-coexpression network for global discovery of conserved genetic modules. Science 302, 249-255.

Stuckey, A., Fischer, A., Miller, D.H., Hillenmeyer, S., Kim, K.K., Ritz, A., Sin- gh, R.K., Raphael, B.J., Brard, L., Brodsky, A.S. (2011). Integrated genomics of ovarian xenograft tumor progression and chemotherapy response. BMC cancer 11, 308.

Sun, B., Jiang, H. (2012). An efficient approach for total synthesis of aminopropyl functionalized ganglioside GM1b. Tetrahedron Letters 53, 5711-5715.

Sun, F., Ding, W., He, J.-H., Wang, X.-J., Ma, Z.-B., Li, Y.-F. (2015). Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor pa- tient survival. BMC cancer 15, 746.

Sun, J., Gong, X., Purow, B., Zhao, Z. (2012). Uncovering microRNA and transc- ription factor mediated regulatory networks in glioblastoma. PLoS Comput Biol 8, e1002488.

Sun, S.-Y., Liu, Z.-P., Zeng, T., Wang, Y., Chen, L. (2013). Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks. Scien- tific reports 3, 2268.

Suzuki, H.I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., Miyazono, K. (2009). Modulation of microRNA processing by p53. Nature 460, 529-533.

Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Ce- pas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K.P. (2014). STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic acids research, gku1003.

Teplinsky, E., Muggia, F. (2015). EGFR and HER2: is there a role in ovarian can- cer? Translational Cancer Research 4, 107-117.

Teschendorff, A.E., Banerji, C.R., Severini, S., Kuehn, R., Sollich, P. (2015). Incre- ased signaling entropy in cancer requires the scale-free property of protein interaction networks. Scientific reports 5.

Tessneer, K.L., Cai, X., Pasula, S., Dong, Y., Liu, X., Chang, B., McManus, J., Hahn, S., Yu, L., Chen, H. (2013). Epsin family of endocytic adaptor proteins as oncogenic regulators of cancer progression. Journal of cancer research updates 2, 144.

Thériault, B.L., Pajovic, S., Bernardini, M.Q., Shaw, P.A., Gallie, B.L. (2012). Ki- nesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer. International journal of cancer 130, 1844-1854.

Thiele, I., Swainston, N., Fleming, R.M., Hoppe, A., Sahoo, S., Aurich, M.K., Haraldsdottir, H., Mo, M.L., Rolfsson, O., Stobbe, M.D. (2013). A commu- nity-driven global reconstruction of human metabolism. Nature biotechno- logy 31, 419-425.

Tian, M., Neil, J.R., Schiemann, W.P. (2011). Transforming growth factor-β and the hallmarks of cancer. Cellular signalling 23, 951-962.

Tillinghast, G.W., Partee, J., Albert, P., Kelley, J.M., Burtow, K.H., Kelly, K. (2003). Analysis of genetic stability at the EP300 and CREBBP loci in a panel of can- cer cell lines. Genes, Chromosomes and Cancer 37, 121-131.

Todeschini, A.-L., Georges, A., Veitia, R.A. (2014). Transcription factors: specific DNA binding and specific gene regulation. Trends in genetics 30, 211-219.

Tsang, J., Zhu, J., van Oudenaarden, A. (2007). MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Molecular cell 26, 753-767.

Tseng, G.C., Ghosh, D., Feingold, E. (2012). Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic acids resear- ch, gkr1265.

Tung, C.S., Mok, S.C., Tsang, Y.T., Zu, Z., Song, H., Liu, J., Deavers, M.T., Malpica, A., Wolf, J.K., Lu, K.H. (2009). PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Modern Patho- logy 22, 1243-1250.

Uhlén, M., Fagerberg, L., Hallström, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A. (2015). Tissue-based map of the human proteome. Science 347, 1260419.

Varadan, V., Anastassiou, D. (2006). Inference of disease-related molecular logic from systems-based microarray analysis. PLoS Comput Biol 2, e68.

Vargova, K., Curik, N., Burda, P., Basova, P., Kulvait, V., Pospisil, V., Savvulidi, F., Kokavec, J., Necas, E., Berkova, A. (2011). MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 117, 3816- 3825.

Vasudevan, S., Tong, Y., Steitz, J.A. (2007). Switching from repression to activati- on: microRNAs can up-regulate translation. Science 318, 1931-1934.

Vathipadiekal, V., Wang, V., Wei, W., Waldron, L., Drapkin, R., Gillette, M., Ska- tes, S., Birrer, M. (2015). Creation of a Human Secretome: A Novel Compo- site Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array. Clinical Cancer Rese- arch 21, 4960-4969.

Vazquez, A., Liu, J., Zhou, Y., Oltvai, Z.N. (2010). Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC systems biology 4, 58.

Vouk, K., Hevir, N., Ribič-Pucelj, M., Haarpaintner, G., Scherb, H., Osredkar, J., Möller, G., Prehn, C., Rižner, T.L., Adamski, J. (2012). Discovery of phospha- tidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Human Reproduction, des152.

Vousden, K.H., Prives, C. (2009). Blinded by the light: the growing complexity of p53. Cell 137, 413-431.

Walley, A., Jacobson, P., Falchi, M., Bottolo, L., Andersson, J., Petretto, E., Bonne- fond, A., Vaillant, E., Lecoeur, C., Vatin, V. (2012). Differential coexpression analysis of obesity-associated networks in human subcutaneous adipose tis- sue. International journal of obesity 36, 137-147.

Wang, B., Love, T.M., Call, M.E., Doench, J.G., Novina, C.D. (2006). Recapitula- tion of short RNA-directed translational gene silencing in vitro. Molecular cell 22, 553-560.

Wang, H.-L., Lu, R.-Q., Xie, S.-H., Zheng, H., Wen, X.-M., Gao, X., Guo, L. (2015).

SIRT7 exhibits oncogenic potential in human ovarian cancer cells. Asian Pac J Cancer Prev 16, 3573-3577.

Wang, J., Duncan, D., Shi, Z., Zhang, B. (2013). WEB-based gene set analysis tool- kit (WebGestalt): update 2013. Nucleic acids research 41, W77-W83.

Wang, J., Lu, M., Qiu, C., Cui, Q. (2010). TransmiR: a transcription factor–mic- roRNA regulation database. Nucleic acids research 38, D119-D122.

Wang, S., Zhang, S. (2011). Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion. Clinical & experimental metastasis 28, 581-591.

Wang, X. (2008). miRDB: a microRNA target prediction and functional annotati- on database with a wiki interface. Rna 14, 1012-1017.

Wang, Y., Chen, L., Wu, Z., Wang, M., Jin, F., Wang, N., Hu, X., Liu, Z., Zhang, C.-Y., Zen, K. (2016). miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL. BMC cancer 16, 826.

Wang, Y., Eddy, J.A., Price, N.D. (2012). Reconstruction of genome-scale meta- bolic models for 126 human tissues using mCADRE. BMC systems biology 6, 153.

Warsow, G., Struckmann, S., Kerkhoff, C., Reimer, T., Engel, N., Fuellen, G. (2013). Differential network analysis applied to preoperative breast cancer chemotherapy response. PLoS One 8, e81784.

Wernicke, S. (2006). Efficient detection of network motifs. IEEE/ACM Transacti- ons on Computational Biology and Bioinformatics 3.

West, J., Bianconi, G., Severini, S., Teschendorff, A.E. (2012). Differential network entropy reveals cancer system hallmarks. Scientific reports 2, 802.

Whitworth, J.M., Londoño-Joshi, A.I., Sellers, J.C., Oliver, P.J., Muccio, D.D., Ati- gadda, V.R., Straughn, J.M. Buchsbaum, D.J. (2012). The impact of novel re- tinoids in combination with platinum chemotherapy on ovarian cancer stem cells. Gynecologic oncology 125, 226-230.

Willis, S., Villalobos, V.M., Gevaert, O., Abramovitz, M., Williams, C., Sikic, B.I., Leyland-Jones, B. (2016). Single gene prognostic biomarkers in ovarian can- cer: A meta-analysis. PLoS One 11, e0149183.

Wilson, A.C., Vadakkadath Meethal, S., Bowen, R.L., Atwood, C.S. (2007). Leuprolide acetate: a drug of diverse clinical applications. Expert opinion on investigational drugs 16, 1851-1863.

Wolf, D.M., Lenburg, M.E., Yau, C., Boudreau, A., van‘t Veer, L.J. (2014). Gene co-expression modules as clinically relevant hallmarks of breast cancer di- versity. PLoS One 9, e88309.

Wong, R.R., Chan, L.K., Tsang, T.P., Lee, C.W., Cheung, T., Yim, S., Siu, N.S., Lee, S.N., Yu, M., Chim, S.S. (2011). CHD5 downregulation associated with poor prognosis in epithelial ovarian cancer. Gynecologic and obstetric investiga- tion 72, 203-207.

Wood, J.R., Nelson-Degrave, V.L., Jansen, E., McAllister, J.M., Mosselman, S., Strauss, J.F. (2005). Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiological genomics 20, 233-243.

Xi, Q., Huang, M., Wang, Y., Zhong, J., Liu, R., Xu, G., Jiang, L., Wang, J., Fang, Z., Yang, S. (2015). The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer. Tumor Biology 36, 4939-4948.

Xia, J., Rocke, D.M., Perry, G., Ray, M. (2014). Differential network analyses of Alzheimer’s disease identify early events in Alzheimer’s disease pathology. International Journal of Alzheimer’s Disease 2014.

Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., Li, T. (2009). miRecords: an integra- ted resource for microRNA–target interactions. Nucleic acids research 37, D105-D110.

Xiong, J., Liu, J., Rayner, S., Li, Y., Chen, S. (2010). Protein-protein interaction reveals synergistic discrimination of cancer phenotype. Cancer informatics 9, 61.

Xu, X., Li, S., Lin, Y., Chen, H., Hu, Z., Mao, Y., Xu, X., Wu, J., Zhu, Y., Zheng, X.

(2013). MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. Journal of translational medicine 11, 276.

Xue, J., Lin, X., Chiu, W.-T., Chen, Y.-H., Yu, G., Liu, M., Feng, X.-H., Sawaya, R., Medema, R.H., Hung, M.-C. (2014). Sustained activation of SMAD3/ SMAD4 by FOXM1 promotes TGF-β–dependent cancer metastasis. The Journal of clinical investigation 124, 564-579.

Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C.V., Zhao, Y., Reynolds, S., Cheng, H., Rupaimoole, R. (2013). Integrated analyses identify a master mic- roRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer cell 23, 186-199.

Yang, H., Kong, W., He, L., Zhao, J.-J., O’Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V. (2008). MicroRNA expression profi- ling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer research 68, 425-433.

Yang, J.-H., Li, J.-H., Shao, P., Zhou, H., Chen, Y.-Q., Qu, L.-H. (2011). starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic acids research 39, D202-D209.

Yang, L., Li, N., Wang, H., Jia, X., Wang, X., Luo, J. (2012). Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncology reports 28, 592-600.

Yang, Y., Hou, N., Wang, X., Wang, L., He, K., Zhao, Z., Zhao, X., Song, T., Huang, C. (2015). miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Oncotarget 6, 16227-16238.

Yang, Z., He, M., Wang, K., Sun, G., Tang, L., Xu, Z. (2014). Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A. Int J Clin Exp Pathol 7, 7563-7570.

Ye, X., Chun, J. (2010). Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Trends in Endocrinology & Metabolism 21, 17-24.

Yeung, T.-L., Leung, C.S., Wong, K.-K., Samimi, G., Thompson, M.S., Liu, J., Zaid, T.M., Ghosh, S., Birrer, M.J., Mok, S.C. (2013). TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor micro- environment. Cancer research 73, 5016-5028.

Yu, H., Gerstein, M. (2006). Genomic analysis of the hierarchical structure of regulatory networks. Proceedings of the National Academy of Sciences 103, 14724-14731.

Yu, H., Tu, K., Wang, Y.-J., Mao, J.-Z., Xie, L., Li, Y.-Y., Li, Y.-X. (2012a). Combi-

natorial network of transcriptional regulation and microRNA regulation in human cancer. BMC systems biology 6, 61.

Yu, X., Lin, J., Zack, D.J., Mendell, J.T., Qian, J. (2008). Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucle- ic acids research 36, 6494-6503.

Yu, X., Vazquez, A., Levine, A.J., Carpizo, D.R. (2012b). Allele-specific p53 mu- tant reactivation. Cancer cell 21, 614-625.

Zhang, B., Pan, X., Cobb, G.P., Anderson, T.A. (2007). microRNAs as oncogenes and tumor suppressors. Developmental biology 302, 1-12.

Zhang, G., He, P., Tan, H., Budhu, A., Gaedcke, J., Ghadimi, B.M., Ried, T., Yfan- tis, H.G., Lee, D.H., Maitra, A. (2013a). Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clinical cancer research 19, 4983-4993.

Zhang, H., Qiu, J., Ye, C., Yang, D., Gao, L., Su, Y., Tang, X., Xu, N., Zhang, D., Xiong, L. (2014a). ROR1 expression correlated with poor clinical outcome in human ovarian cancer. Scientific reports 4, 5811.

Zhang, J., Song, Y., Zhang, C., Zhi, X., Fu, H., Ma, Y., Chen, Y., Pan, F., Wang, K., Ni, J. (2015). Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancer. Theranostics 5, 733.

Zhang, J., Xiang, Y., Ding, L., Borlawsky, T.B., Ozer, H.G., Jin, R., Payne, P., Huang,

K. (2010). Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia. BMC bioinformatics 11, S5.

Zhang, L., Liu, W., Hao, Q., Bao, L., Wang, K. (2012). Folate intake and methyle- netetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk. International journal of molecular sciences 13, 4009-4020.

Zhang, Q., Burdette, J.E., Wang, J.-P. (2014b). Integrative network analysis of TCGA data for ovarian cancer. BMC systems biology 8, 1338.

Zhang, W., Ota, T., Shridhar, V., Chien, J., Wu, B., Kuang, R. (2013b). Network-ba- sed survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Comput Biol 9, e1002975.

Zhang, X.-F., Ou-Yang, L., Zhao, X.-M., Yan, H. (2016). Differential network analysis from cross-platform gene expression data. Scientific Reports 6.

Zhou, Y., Ferguson, J., Chang, J.T., Kluger, Y. (2007). Inter-and intra-combina- torial regulation by transcription factors and microRNAs. BMC genomics 8, 396.

Zhou, Y., Liu, Y., Li, K., Zhang, R., Qiu, F., Zhao, N., Xu, Y. (2015). ICan: an integ- rated co-alteration network to identify ovarian cancer-related genes. PLoS One 10, e0116095.

Zhu, H., Yu, J.J. (2010). Gene expression patterns in the histopathological classi- fication of epithelial ovarian cancer. Experimental and therapeutic medicine 1, 187-192.

Zickenrott, S., Angarica, V., Upadhyaya, B., Del Sol, A. (2016). Prediction of di- sease–gene–drug relationships following a differential network analysis. Cell death & disease 7, e2040.